NDC 11673-889 - Cold and Flu Daytime Nighttime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-889
- Package NDCs from labels
- 11673-889-45
- Manufacturer
- Target Corporation | LNK International, Inc.
- Effective date
- 2025-04-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Target 44-042078 | Target Corporation | LNK International, Inc. | 2025-04-26 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-889-45 | Cold and FluDaytime Nighttime | 177 mL in 1 BOTTLE, PLASTIC | SOLUTION | 177 mL | 650 mg in 20mL | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-889 | COLD AND FLU DAYTIME NIGHTTIME (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, TRIPROLIDINE HCL) KIT [TARGET CORPORATION] | 6 | Unmatched | 20250428_c14a2643-ca13-4574-9928-47ec57c2c1c4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone APAP | HYDROCODONE APAP | Direct_Rx | deaa53c1-81ed-7497-e053-2995a90a07cc | 2025-01-28 | Warnings, Adverse reactions | 362O9ITL9D |
| Severe Congestion and Cough Max | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Best Choice | 8c878e47-94f4-484f-bdd8-6d87ac2440d8 | 2025-01-28 | Warnings | 9D2RTI9KYH 04JA59TNSJ 495W7451VQ |
| Hemorrhoidal | PAIN RELIEF | NeilMed Pharmaceuticals Inc. | 038a2cf5-1b72-227b-e063-6394a90a84ad | 2025-01-24 | Warnings | 04JA59TNSJ |
| Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | c9d0e9c8-379f-4895-b272-329efab575c4 | 2025-01-24 | Warnings, Adverse reactions | B22547B95K |
| Childrens Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 38b839b6-de7d-4f33-a19a-efc92cdad92c | 2025-01-24 | Warnings | 362O9ITL9D |
| Mucus Relief Extended Release | GUAIFENESIN | Redpharm Drug Inc. | f4c1e725-bcae-2255-e053-2995a90ad335 | 2025-01-23 | Warnings | 495W7451VQ |
| good sense pain relief | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 523b68da-cd2a-4960-95e7-de5d51ce33c1 | 2025-01-23 | Warnings | 362O9ITL9D |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | Caplin Steriles Limited | 1b3eec91-5be5-4010-bf92-4c3e72b39b2a | 2025-01-23 | Warnings, Adverse reactions | 04JA59TNSJ |
| Sodium Citrate 4% w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 0775912f-f14a-4967-ac00-c8c1b36040bf | 2025-01-23 | Warnings, Adverse reactions | B22547B95K |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Direct_Rx | e78e50c0-36da-528e-e053-2995a90a3d80 | 2025-01-22 | Warnings, Adverse reactions | 362O9ITL9D |
| Tramadol Hydrochloride and Acetaminophen | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | Direct_Rx | e8a7c995-e473-ca87-e053-2995a90a5b80 | 2025-01-22 | Warnings, Adverse reactions | 362O9ITL9D |
| HYDROCODONE/APAP | HYDROCODONE/APAP | Direct_Rx | efe3b2eb-5c26-3783-e053-2995a90a6ba8 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Percocet | OXYCODONE/APAP | Direct_Rx | ee151649-b52a-0a51-e053-2a95a90a6c35 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Norco | HYDROCODONE/APAP | Direct_Rx | ee248dfd-7aa7-7dcc-e053-2995a90af19f | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone/APAP | HYDROCODONE/APAP | Direct_Rx | f0e66441-668a-7ab8-e053-2995a90aba4f | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| OASIS Tears Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 00071697-4ac6-4962-8eee-388b8b52bd40 | 2025-01-22 | Warnings | PDC6A3C0OX |
| OASIS Tears Plus Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | ea931c0f-c61e-4771-84f1-0274b1c3e28e | 2025-01-22 | Warnings | PDC6A3C0OX |
| Pharbetol | ACETAMINOPHEN 325 MG | Ulai Health LLC | 55bb7e6c-e98c-48bd-b7bb-9848ff0273ca | 2025-01-20 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN PM | ACETAMINOPHEN 500MG / DIPHENHYDRAMINE HCL 25MG | Ulai Health LLC | d4a568c9-a721-48d1-aebc-fc65444947ce | 2025-01-20 | Warnings | 362O9ITL9D |
| Pharbinex | GUAIFENESIN 400MG | Ulai Health LLC | 4eafa81a-aeee-4c97-85d6-594902b10919 | 2025-01-20 | 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.